Symposium C3
Manufacturing Concepts for Individualised Therapies

Tuesday 23 May 2017
Stockholmsmässan : K11


Recent breakthroughs in diagnostics, including genotyping and biomarkers, have paved the way towards implementation of ‘precision medicine’ intended to meet the therapeutic needs of each individual patient. To fully achieve societal benefits of individualised therapies, conventional manufacturing platforms must be adapted for mass customization. This session will focus on the challenges and opportunities associated with enabling future mass customized formulation and manufacturing technologies needed for precision pharmaceutics. 

Chair: Staffan Folestad (Sweden)



15:00 – 15:35 Introduction to manufacturing concepts for individualized therapies – where are we in pharma
Staffan Folestad, AstraZeneca, Sweden

15:35 – 16:10 Additive manufacturing of individualised medicines
Niklas Sandler, Åbo Akademi University, Finland

16:10 – 16:30 BREAK

16:30 – 17:05 Design of nanopharmaceuticals that are able to overcome biological barriers
Maria José Alonso, University of Santiago de Compostela, Spain

17:05 - 17:40 Innovative developments in patient centric formulations
Alvaro Goyanes, UCL, UK

17:40 – 18:00 Panel discussion focusing on "Manufacturing concepts for individualised therapies – where could pharma be?
Staffan Folestad, AstraZeneca, Sweden